Wong RJ, Jain MK, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Thamer M. Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment in four large health care organizations. Am J Gastroenterol. 2018;113:1329-338. Read our paper.
Jain MK, Thamer M, Therapondos G, Shiffman ML, Kshirsagar O, Clark C, Wong RJ. Has access to HCV therapy changed for patients with mental health and substance use disorders in the DAA period? Hepatology 2019; 69:51-63. Read our paper.
Chen E, North CS, Fatunde O, Bernstein I, Salari S, Day B, Jain MK. Knowledge and attitudes about hepatitis C virus infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults. J Viral Hepat 2013: 20:708-714. Read our paper:
Pundhir P, North CS, Oluwatomilade F, Jain MK. Health beliefs and co-morbidities associated with appointment-keeping behavior among HCV and HIV/HCV patients. J Community Health. 2016;41:30-7. Read our paper.